Semaglutide is a glucagon-like peptide-1 receptor agonist which has been shown to reduce body weight and improve health status in patients with obesity related heart failure with preserved
Some have called Lipoprotein(a), known in short as Lp(a) as low density lipoprotein particle on steroids, while others have called it the ‘ugly’ cholesterol where as LDL cholesterol
It is well known that severe hypertriglyceridemia with serum triglyceride levels 500 mg/dL or more is an important risk factor for acute pancreatitis. Severe hypertriglyceridemia is also a
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common behavioral disorder and treatment can ameliorate symptoms and improve quality of life. But most ADHD treatments can increase heart
It is already known that high intake of ultraprocessed food is associated with higher cardimetabolic risk in adults. A new study published in the Journal of American Medical Association
After the approval of mavacamten, a novel cardiac myosin inhibitor for symptomatic hypertrophic obstructive cardiomyopathy, a new medication in the same group is getting ready. Hypertrophic obstructive cardiomyopathy
Novel gene editing treatment with exa-cel has been recently approved for treatment of severe sickle cell disease and transfusion-dependent β-thalassemia [1]. It was six decades back that it
Hypertrophic cardiomyopathy, a disease with thickening of heart muscle, is an important cause of sudden cardiac death in athletes. But the 2024 Guidelines for Management of Hypertrophic Cardiomyopathy,
Holt-Oram Syndrome is a familial heart disease with skeletal malformations described by Mary Holt and Samuel Oram. Initial description was familial atrial septal defect associated with abnormalities of
It is well known that lipoprotein(a) is associated with increased risk of cardiovascular disease, including calcific aortic valve disease. New treatment modalities are being investigated in clincal trials
